Travoprost

Common brands: Travatan Z, Travoprost Ophthalmic Soluton, Xalatan, Xelpros, Latanoprost

Top reporter: Novartis Pharmaceuticals Corporation

Prostaglandin Analog [EPC]Carbonic Anhydrase Inhibitor [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Corticosteroid [EPC]Platelet Aggregation Inhibitor [EPC]
8,507
Total Reports
1,687
Serious Reports
327
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (3.84%)

Patient Demographics

Male
3,081
Female
4,866

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Travoprost.

# Reaction Reports % of Total
1 TREATMENT FAILURE 1,946
23.0%
2 DRUG INEFFECTIVE 534
6.3%
3 OCULAR HYPERAEMIA 493
5.8%
4 EYE IRRITATION 481
5.7%
5 EYE PAIN 340
4.0%
6 INTRAOCULAR PRESSURE INCREASED 297
3.5%
7 HYPERSENSITIVITY 269
3.2%
8 FATIGUE 263
3.1%
9 GLAUCOMA 256
3.0%
10 HEADACHE 228
2.7%
11 DIZZINESS 227
2.7%
12 VISION BLURRED 227
2.7%
13 VISUAL IMPAIRMENT 215
2.5%
14 DEATH 205
2.4%
15 DYSPNOEA 200
2.4%
16 FALL 188
2.2%
17 OFF LABEL USE 183
2.2%
18 DIARRHOEA 182
2.2%
19 NAUSEA 181
2.1%
20 MALAISE 179
2.1%
21 PRODUCT DOSE OMISSION ISSUE 160
1.9%
22 EYE PRURITUS 155
1.8%
23 COUGH 146
1.7%
24 PAIN 146
1.7%
25 ASTHENIA 145
1.7%
26 DRY EYE 140
1.7%
27 ARTHRALGIA 134
1.6%
28 DRUG HYPERSENSITIVITY 124
1.5%
29 PNEUMONIA 111
1.3%
30 PAIN IN EXTREMITY 108
1.3%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.